首页> 外文期刊>Nature >Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex
【24h】

Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex

机译:人symplekin-Ssu72-CTD磷酸肽复合物的晶体结构

获取原文
获取原文并翻译 | 示例
           

摘要

Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukary-otic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (Pol II). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 A resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxy-terminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of anti-parallel a-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phospho-tyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 A from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.
机译:Symplekin(酵母中的Pta1)是大型蛋白质复合物中的支架,是真核信使RNA前体(pre-mRNA)的3'端裂解和聚腺苷酸化所必需的;它也参与RNA聚合酶II(Pol II)的转录起始和终止。尽管该功能的分子基础尚不清楚,但Symplekin介导了该机制中许多不同蛋白质之间的相互作用。在这里,我们报道了与Pol II羧基末端结构域(CTD)Ser 5磷酸酶Ssu72(参考文献7、10--)形成的三元复合物中人symplekin的氨基末端结构域(残基30-340)的分辨率为2.4 A的晶体结构17)和CTD Ser 5磷酸肽。 symplekin的N末端结构域具有ARM或HEAT折叠,并以弧形排列了七对反平行的a螺旋。 Ssu72的结构与低分子量磷酸酪氨酸蛋白磷酸酶的结构有些相似,尽管Ssu72具有独特的活性位点景观以及C末端的额外结构特征,这些特征对于与symplekin相互作用非常重要。 Ssu72绑定到symplekin的凹面,并且该界面中的工程突变可以消除两种蛋白质之间的相互作用。 CTD肽以顺式构型与pSer 5-Pro 6肽键结合在Ssu72的活性位点中,这与所有其他已知的CTD肽构象形成对比。尽管Ssu72的活性位点距与symplekin的界面约25 A,但我们发现symplekin的N末端结构域在体外刺激了Ssu72 CTD磷酸酶的活性。此外,Symplekin的N末端结构域在体外可抑制聚腺苷酸化,但仅在与转录偶联时才起作用。因为具有催化活性的Ssu72克服了这种抑制作用,所以我们的结果显示了哺乳动物Ssu72在转录偶联的mRNA前3'末端加工中的作用。

著录项

  • 来源
    《Nature》 |2010年第7316期|P.729-733|共5页
  • 作者单位

    Department of Biological Sciences, Columbia University, New York, New York 10027, USA;

    rnDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA;

    rnDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China;

    rnDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA;

    rnDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA;

    rnDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA;

    rnDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号